Cancer immunotherapies have given patients with particularly intractable cancers new hope, but not everyone benefits. One such immunotherapy, known as CAR T-cell therapy, works only in about a third of the people who take it—and the reason may lie in the microbes residing in our guts. Over the next year, a team of Stanford and
A new nuclear medicine method for detecting malignant melanoma, one of the most aggressive skin cancers, has been successfully tested for the first time in humans and could improve detection of both primary and metastatic melanoma. The research is featured in the January 2019 print issue of the Journal of Nuclear Medicine. The National Cancer
‘It’s a shambles.. it makes me very angry’: Family of girl, 15, who died from allergic reaction after eating Pret sandwich slam findings of new probe that shows bakeries still flouting labelling rules Reporters from BBC1’s Watchdog Live posed as customers with food allergies Sainsbury’s, Tesco and Asda found to have incorrect and confusing information
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok